Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Gains from Investment Securities (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Gains from Investment Securities for 16 consecutive years, with $37000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 49.32% to $37000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4000.0 through Dec 2025, down 136.36% year-over-year, with the annual reading at -$4000.0 for FY2025, 136.36% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $37000.0 at Niagen Bioscience, up from -$15000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $73000.0 in Q4 2024, with the low at -$89000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is -$2315.8, with a median of $3000.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities surged 266.67% in 2022, then crashed 423.53% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $31000.0 in 2021, then plummeted by 154.84% to -$17000.0 in 2022, then plummeted by 423.53% to -$89000.0 in 2023, then soared by 182.02% to $73000.0 in 2024, then crashed by 49.32% to $37000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $37000.0, -$15000.0, and -$29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.